Toripalimab Evidence Journey in Cancer Care

By Rene Pretorius

April 9, 2025

The FDA approved toripalimab (Loqtorzi) on October 27, 2023, as the first immunot...
NICE Breakthrough: Record Positive Recommendations for Blood Cancer Treatment...
Approval of Pembrolizumab Enfortumab Therapy: Insights on Efficacy, Costs, an...
Cancer Control Month 2025: Key Takeaways from President Trump’s National Call...
Tobacco Head Neck Cancer: Unraveling Mutational Signatures and Prevention Str...
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Oral Cancer in East Africa: The Need for Early Detection
Engineering Resilience: Mastering Pharma Patent Expiration Strategy
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
HPV Testing in Head and Neck Squamous Cell Carcinoma
Oral Health in Africa: Promoting Collaborative Solutions
Early Benefit Assessment of Tislelizumab NSCLC Treatment: Insights and Implic...
Advances in Colorectal Cancer Screening: Access and Cost